Peptides
NA-Epithalon: why the modified form needs its own evidence
What is it?
NA-Epithalon is a catalog label for a modified form of Epithalon, the four-amino-acid peptide Ala-Glu-Asp-Gly. Adding an N-acetyl group changes the compound. Any additional modification or salt form should be verified from the product’s actual analytical documentation. The parent peptide and the modified vial should not be treated as identical. [1]
What do studies show?
An often-cited laboratory study reported that parent Epithalon altered telomerase activity and telomere length in cultured human cells. A cell dish does not establish that a person taking the peptide will have longer telomeres, live longer, or avoid disease. Studies of the pineal extract Epithalamin are also not studies of this synthetic modified product. We did not identify a controlled human outcome study of NA-Epithalon. [2]
Safety
Without human exposure or formulation-specific studies, risks and purity of the modified vial are unknown. The FDA has flagged uncertainty about immunogenicity and peptide impurities even for parent Epitalon in compounding contexts; those findings cannot certify the safety of an N-acetyl version. [3]
DOSE STATUS
How much?
EVIDENCE CONTEXT
Why?
The cited evidence does not establish a dose for this use or product.
No effective or safe human dose of NA-Epithalon has been established. Anecdotal protocols for unmodified Epithalon cannot be converted to this variant without pharmacokinetic and safety data. The catalog’s 10 mg vial size is inventory information, not a recommended dose. We found no attributable, formulation-matched educator protocol to report. [1,3]